## YONG LI

| | Title| Professor  
---|---  
Institution| Baylor College of Medicine  
Department| Department of Medicine  
Address| One Baylor Plaza  
Houston, TX 77030  
  
Email|
![](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/EmailHandler.ashx?msg=D6Q%2b5ivrKav3RYKj5X%2fX&rnd=0a898642-b3b5-4aae-9637-8fe1ec07f46f)  
vCard| [Download
vCard](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/vcard.aspx?subject=28999515)  
  
![](https://profiles.viictr.org/profile/Modules/CustomViewPersonGeneralInfo/PhotoHandler.ashx?NodeID=28999515&cachekey=fe58de9e-481e-47bf-99c9-abb6d30a0eaa)  
  

  
![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
Research  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
research activities and funding

U54CA272691 (LI, YONG)Sep 1, 2023 - Aug 31, 2027NIH  
Cancer Prevention-Interception Against MGUS Progression  
Role: Principal Investigator  
---  
  
* * *  
  
R01CA278089 (LI, YONG)Apr 17, 2023 - Mar 31, 2028NIH  
Optimizing Syngeneic Mouse Models to Target Mutant p53  
Role: Principal Investigator  
  
* * *  
  
R01CA271546 (LI, YONG)Dec 16, 2022 - Nov 30, 2027NIH  
Therapeutic Targeting a Non-Hodgkin Lymphoma Driver Using AI  
Role: Principal Investigator  
  
* * *  
  
R41CA265459 (CHEN, SHU-HSIA)Jun 6, 2022 - May 31, 2024NIH  
Development of Therapeutic Cancer Vaccine  
Role Description: Yong Li is the PI of the subaward to Baylor College of
Medicine  
Role: Co-Investigator  
  
* * *  
  
R01CA229080 (LI, YONG)Jun 15, 2018 - May 31, 2023NIH  
Dietary Carcinogens for Colorectal Cancer  
Role: Principal Investigator  
  
* * *  
  
R01CA219556 (LI, YONG)May 10, 2018 - Apr 30, 2024NIH  
TP53 Germline Mutations: Beyond LFS  
Role: Principal Investigator  
  
* * *  
  
R01CA187415 (LI, YONG)Apr 20, 2015 - Mar 31, 2021NIH  
MYC as a Biomarker in Aggressive Non-Hodgkin Lymphoma  
Role: Principal Investigator  
  
* * *  
  
R01CA177810 (LI, YONG)Apr 8, 2015 - Mar 31, 2021NIH  
Modulation of MicroRNAs with Xenobiotics to Target c-Myc  
Role: Principal Investigator  
  
* * *  
  
R21HL120050 (LI, YONG)Jun 1, 2014 - Aug 31, 2017NIH  
MicroRNAs as Biomarkers for Tobacco Exposure and Heart Disease  
Role: Principal Investigator  
  
* * *  
  
R01ES017274 (LI, YONG)Sep 26, 2009 - Jun 30, 2012NIH  
Role of Retroelements in Environmental Atherogenesis  
Role: Principal Investigator  
  
* * *  
  
R01CA138688 (LI, YONG)Apr 1, 2009 - Aug 31, 2019NIH  
Convergence of MicroRNAs and p53 Signaling in Multiple Myeloma: Environmental
Co  
Role: Principal Investigator  
  
* * *  
  
P30ES014443 (LI, YONG)Jun 4, 2007 - Mar 31, 2012NIH  
Center for Environmental Genomics and Integrative Biology  
Role: Principal Investigator  
  
  
![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
Bibliographic  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
selected publications

Publications listed below are automatically derived from MEDLINE/PubMed and
other sources, which might result in incorrect or missing publications.
Faculty can
[login](https://profiles.viictr.org/loginOptions.aspx?pin=send&method=login&edit=true)
to make corrections and additions.

Newest | Oldest | Most Cited | Most Discussed | Timeline | Field Summary | Plain Text

PMC Citations indicate the number of times the publication was cited by
articles in PubMed Central, and the Altmetric score represents citations in
news articles and social media. (Note that publications are often cited in
additional ways that are not shown here.) Fields are based on how the National
Library of Medicine (NLM) classifies the publication's journal and might not
represent the specific topic of the publication. Translation tags are based on
the publication type and the MeSH terms NLM assigns to the publication. Some
publications (especially newer ones and publications not in PubMed) might not
yet be assigned Field or Translation tags.) Click a Field or Translation tag
to filter the publications.

  1. [Chai D](https://profiles.viictr.org/profile/35895164), Wang J, Fan C, Lim JM, Wang X, Neeli P, [Yu X](https://profiles.viictr.org/profile/28999565), [Young KH](https://profiles.viictr.org/profile/12582816), **Li Y**. Remodeling of anti-tumor immunity with antibodies targeting a p53 mutant. J Hematol Oncol. 2024 Jun 18; 17(1):45. PMID: [38886748](//www.ncbi.nlm.nih.gov/pubmed/38886748); PMCID: [PMC11184848](//www.ncbi.nlm.nih.gov/pmc/articles/PMC11184848).

Citations:  Fields:

Hem HematologyNeo Neoplasms

Translation:HumansAnimalsCells

  2. Li JR, Arsang-Jang S, Cheng Y, Sun F, D'Souza A, Dhakal B, Hari P, Huang Q, Auer P, **Li Y** , Urrutia R, Zhan F, Shaughnessy JD, Janz S, Dong J, Cheng C. Enhancing prognostic power in multiple myeloma using a plasma cell signature derived from single-cell RNA sequencing. Blood Cancer J. 2024 Mar 06; 14(1):38. PMID: [38443358](//www.ncbi.nlm.nih.gov/pubmed/38443358); PMCID: [PMC10915134](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10915134).

Citations:  Fields:

All Allergy and ImmunologyHem HematologyNeo Neoplasms

Translation:HumansCells

  3. Sobhani N, Tardiel-Cyril DR, [Chai D](https://profiles.viictr.org/profile/35895164), Generali D, Li JR, [Vazquez-Perez J](https://profiles.viictr.org/profile/31194421), Lim JM, Morris R, [Bullock ZN](https://profiles.viictr.org/profile/34774549), Davtyan A, Cheng C, [Decker WK](https://profiles.viictr.org/profile/267087), **Li Y**. Artificial intelligence-powered discovery of small molecules inhibiting CTLA-4 in cancer. BJC Rep. 2024; 2. PMID: [38312352](//www.ncbi.nlm.nih.gov/pubmed/38312352); PMCID: [PMC10838660](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10838660).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/38312352/citedby/)

  4. Huang M, Liu Y, Yan Q, Peng M, Ge J, Mo Y, Wang Y, Wang F, Zeng Z, **Li Y** , Fan C, Xiong W. NK cells as powerful therapeutic tool in cancer immunotherapy. Cell Oncol (Dordr). 2024 Jun; 47(3):733-757. PMID: [38170381](//www.ncbi.nlm.nih.gov/pubmed/38170381).

Citations:

  5. [Xu-Monette ZY](https://profiles.viictr.org/profile/17440027), **Li Y** , Snyder T, Yu T, Lu T, Tzankov A, Visco C, Bhagat G, Qian W, Dybkaer K, Chiu A, Tam W, Zu Y, Hsi ED, [Hagemeister FB](https://profiles.viictr.org/profile/12583270), Wang Y, Go H, Ponzoni M, Ferreri AJM, M?ller MB, Parsons BM, Fan X, van Krieken JH, Piris MA, Winter JN, Au Q, Kirsch I, Zhang M, Shaughnessy J, Xu B, [Young KH](https://profiles.viictr.org/profile/12582816). Tumor-Infiltrating Normal B Cells Revealed by Immunoglobulin Repertoire Clonotype Analysis Are Highly Prognostic and Crucial for Antitumor Immune Responses in DLBCL. Clin Cancer Res. 2023 12 01; 29(23):4808-4821. PMID: [37728879](//www.ncbi.nlm.nih.gov/pubmed/37728879); PMCID: [PMC10842978](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10842978).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/37728879/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  6. Li H, Song W, Wu J, Shi Z, Gao Y, Li J, Han L, Zhang J, Li Z, **Li Y** , Zhang M. CAR-T cells targeting CD38 and LMP1 exhibit robust antitumour activity against NK/T cell lymphoma. BMC Med. 2023 08 30; 21(1):330. PMID: [37649020](//www.ncbi.nlm.nih.gov/pubmed/37649020); PMCID: [PMC10470138](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10470138).

Citations:

  7. Zhou S, [Chai D](https://profiles.viictr.org/profile/35895164), Wang X, Neeli P, [Yu X](https://profiles.viictr.org/profile/28999565), Davtyan A, [Young K](https://profiles.viictr.org/profile/12582816), **Li Y**. AI-powered discovery of a novel p53-Y220C reactivator. Front Oncol. 2023; 13:1229696. PMID: [37593097](//www.ncbi.nlm.nih.gov/pubmed/37593097); PMCID: [PMC10430779](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10430779).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/37593097/citedby/)

  8. Brown CJ, **Li Y** , Sabapathy K. Editorial: Overcoming the cell membrane to target intracellular oncoproteins. Front Oncol. 2023; 13:1222095. PMID: [37503327](//www.ncbi.nlm.nih.gov/pubmed/37503327); PMCID: [PMC10369770](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10369770).

Citations:

  9. [Chai D](https://profiles.viictr.org/profile/35895164), Wang X, Neeli P, Zhou S, Yu X, Sabapathy K, **Li Y**. DNA-delivered monoclonal antibodies targeting the p53 R175H mutant epitope inhibit tumor development in mice. Genes Dis. 2024 Jul; 11(4):100994. PMID: [38560504](//www.ncbi.nlm.nih.gov/pubmed/38560504); PMCID: [PMC10980946](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10980946).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/38560504/citedby/)

  10. Garcia-Sanz R, Varettoni M, Jiménez C, Ferrero S, Poulain S, San-Miguel JF, Guerrera ML, Drandi D, Bagratuni T, McMaster M, Roccaro AM, Roos-Weil D, Leiba M, **LI Y** , Qiu L, Hou J, De Larrea CF, Castillo JJ, Dimopoulos M, Owen RG, Treon SP, Hunter ZR. Report of Consensus Panel 3 from the 11th International workshop on Waldenström's Macroglobulinemia: Recommendations for molecular diagnosis in Waldenström's Macroglobulinemia. Semin Hematol. 2023; 60(2):90-96. [View Publication](http://10.1053/j.seminhematol.2023.03.007).

  11. Mo Y, Wang Y, Wang Y, Deng X, Yan Q, Fan C, Zhang S, Zhang S, Gong Z, Shi L, Liao Q, Guo C, **LI Y** , Li G, Zeng Z, Jiang W, Xiong W, Xiang B. Circular RNA circPVT1 promotes nasopharyngeal carcinoma metastasis via the β-TrCP/c-Myc/SRSF1 positive feedback loop. mol cancer. 2023; 21(1):192. [View Publication](http://doi: 10.1186/s12943-022-01659-w).

  12. Gopalan V, Nilsen T, Gopalan V, Altman AM, Stark BC, Feinstein SI, Koski R, Mickiewicz C, Stark B, Gegenheimer P, Kirsebom LA, Arnez JG, Forster AC, Kazakov SA, Yuan Y, Liu F, Jarrous N, Yang L, Jiang G, Jiang T, Rosenbaum JL, Miller G, DiMaio D, Carlson JR, McClain WH, Mathews MB, Kaempfer R, Deutscher MP, Chen LL, **LI Y** , Wang E, Patutina O, Zenkova M, Vlassov V, Lucks JB, Gopalan V. Tribute to Sidney Altman. RNA. 2023; 28(11):1393-1429.

  13. Tardon A, Bojesen SE, Rennert G, Field JK, Kiemeney LA, Zienolddiny S, Grankvist K, Johansson M, Hong YC, Cheng C, Hong W, Li Y, Xiao X, McKay J, [Han Y](https://profiles.viictr.org/profile/28999010), [Byun J](https://profiles.viictr.org/profile/28999157), Peng B, Albanes D, Lam S, Chen C, Landi MT, Johansson M, Risch A, Bickeb?ller H, Wichmann HE, Christiani DC, Arnold S, Goodman G, Davies MPA, [Shete SS](https://profiles.viictr.org/profile/12583745), Le Marchand L, Liu G, Hung RJ, Andrew AS, Zhu M, Shen H, Cox A, Yuan JM, Lazarus P, Schabath MB, Aldrich MC, Brennan P, **Li Y** , [Gorlova O](https://profiles.viictr.org/profile/28999534), [Gorlov I](https://profiles.viictr.org/profile/29494075), [Amos CI](https://profiles.viictr.org/profile/23372697), INTEGRAL-ILCCO Lung Cancer Consortium. Mosaic Chromosomal Alterations Are Associated With Increased Lung Cancer Risk: Insight From the INTEGRAL-ILCCO Cohort Analysis. J Thorac Oncol. 2023 08; 18(8):1003-1016. PMID: [37150255](//www.ncbi.nlm.nih.gov/pubmed/37150255); PMCID: [PMC10435278](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10435278).

Citations:  Fields:

Neo NeoplasmsPul Pulmonary Medicine

Translation:Humans

  14. **Li Y** , [Xu-Monette ZY](https://profiles.viictr.org/profile/17440027), Abramson J, Sohani AR, Bhagat G, Tzankov A, Visco C, Zhang S, Dybkaer K, Pan Z, Xu M, Tam W, Zu Y, Hsi ED, [Hagemeister FB](https://profiles.viictr.org/profile/12583270), Go H, van Krieken JH, Winter JN, Ponzoni M, Ferreri AJM, M?ller MB, Piris MA, Wang Y, Zhang M, [Young KH](https://profiles.viictr.org/profile/12582816). EBV-positive DLBCL frequently harbors somatic mutations associated with clonal hematopoiesis of indeterminate potential. Blood Adv. 2023 04 11; 7(7):1308-1311. PMID: [36399513](//www.ncbi.nlm.nih.gov/pubmed/36399513); PMCID: [PMC10119604](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10119604).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/36399513/citedby/) Fields:

Hem Hematology

Translation:Cells

  15. [Yu X](https://profiles.viictr.org/profile/28999565), Li W, Liu H, Wang X, [Coarfa C](https://profiles.viictr.org/profile/265668), Cheng C, Yu X, Zeng Z, Cao Y, [Young KH](https://profiles.viictr.org/profile/12582816), **Li Y**. PD-L1 translocation to the plasma membrane enables tumor immune evasion through MIB2 ubiquitination. J Clin Invest. 2023 02 01; 133(3). PMID: [36719382](//www.ncbi.nlm.nih.gov/pubmed/36719382); PMCID: [PMC9888393](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9888393).

Citations:  Fields:

Med Medicine (General)

Translation:AnimalsCells

  16. Wang X, [Yu X](https://profiles.viictr.org/profile/28999565), Li W, Neeli P, Liu M, Li L, Zhang M, Fang X, [Young KH](https://profiles.viictr.org/profile/12582816), **Li Y**. Expanding anti-CD38 immunotherapy for lymphoid malignancies. J Exp Clin Cancer Res. 2022 Jun 28; 41(1):210. PMID: [35765110](//www.ncbi.nlm.nih.gov/pubmed/35765110); PMCID: [PMC9237984](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9237984).

Citations:  Fields:

Neo Neoplasms

Translation:HumansAnimals

  17. Sobhani N, Scaggiante B, Morris R, [Chai D](https://profiles.viictr.org/profile/35895164), Catalano M, Tardiel-Cyril DR, Neeli P, Roviello G, Mondani G, **Li Y**. Therapeutic cancer vaccines: From biological mechanisms and engineering to ongoing clinical trials. Cancer Treat Rev. 2022 Sep; 109:102429. PMID: [35759856](//www.ncbi.nlm.nih.gov/pubmed/35759856); PMCID: [PMC9217071](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9217071).

Citations:  Fields:

Ant Antineoplastic AgentsNeo Neoplasms

  18. [Xu-Monette ZY](https://profiles.viictr.org/profile/17440027), Wei L, Fang X, Au Q, Nunns H, Tzankov A, Zhu F, Visco C, Bhagat G, Dybkaer K, Chiu A, Tam W, Zu Y, Hsi ED, [Hagemeister FB](https://profiles.viictr.org/profile/12583270), Sun X, Han X, Go H, Ponzoni M, Parsons BM, van Krieken JH, Winter JN, **Li Y** , Xu B, Albitar M, You H, [Young KH](https://profiles.viictr.org/profile/12582816), Nagy M, Ferreri AJM, M?ller MB, Piris MA. Genetic Subtyping and Phenotypic Characterization of the Immune Microenvironment and MYC/BCL2 Double Expression Reveal Heterogeneity in Diffuse Large B-cell Lymphoma. Clin Cancer Res. 2022 Mar 01; 28(5):972-983. PMID: [34980601](//www.ncbi.nlm.nih.gov/pubmed/34980601); PMCID: [PMC9137388](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9137388).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/34980601/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  19. Albitar M, Zhang H, Goy A, [Xu-Monette ZY](https://profiles.viictr.org/profile/17440027), Bhagat G, Visco C, Tzankov A, Fang X, Zhu F, Dybkaer K, Chiu A, Tam W, Zu Y, Hsi ED, [Hagemeister FB](https://profiles.viictr.org/profile/12583270), Huh J, Ponzoni M, Parsons BM, van Krieken JH, Winter JN, **Li Y** , Xu B, [Young KH](https://profiles.viictr.org/profile/12582816), Ferreri AJM, M?ller MB, Piris MA. Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms. Blood Cancer J. 2022 02 01; 12(2):25. PMID: [35105854](//www.ncbi.nlm.nih.gov/pubmed/35105854); PMCID: [PMC8807629](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8807629).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/35105854/citedby/) Fields:

All Allergy and ImmunologyHem HematologyNeo Neoplasms

Translation:HumansCells

  20. [Yu X](https://profiles.viictr.org/profile/28999565), Li W, [Young KH](https://profiles.viictr.org/profile/12582816), **Li Y**. Posttranslational Modifications in PD-L1 Turnover and Function: From Cradle to Grave. Biomedicines. 2021 Nov 16; 9(11). PMID: [34829931](//www.ncbi.nlm.nih.gov/pubmed/34829931); PMCID: [PMC8615371](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8615371).

Citations:

  21. Zhou S, Fan C, Zeng Z, [Young KH](https://profiles.viictr.org/profile/12582816), **Li Y**. Clinical and Immunological Effects of p53-Targeting Vaccines. Front Cell Dev Biol. 2021; 9:762796. PMID: [34805170](//www.ncbi.nlm.nih.gov/pubmed/34805170); PMCID: [PMC8595300](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8595300).

Citations:

  22. Zhong Y, Yang L, Xiong F, He Y, Tang Y, Shi L, Fan S, Li Z, Zhang S, Gong Z, Guo C, Liao Q, Zhou Y, Zhou M, Xiang B, Li X, **Li Y** , Zeng Z, Li G, Xiong W. Long non-coding RNA AFAP1-AS1 accelerates lung cancer cells migration and invasion by interacting with SNIP1 to upregulate c-Myc. Signal Transduct Target Ther. 2021 06 25; 6(1):240. PMID: [34168109](//www.ncbi.nlm.nih.gov/pubmed/34168109); PMCID: [PMC8225811](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8225811).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/34168109/citedby/) Fields:

Cel Cell BiologyDru Drug Therapy

Translation:HumansAnimalsCells

  23. Xiong F, Zhu K, Deng S, Huang H, Yang L, Gong Z, Shi L, He Y, Tang Y, Liao Q, Yu J, Li X, **Li Y** , Li G, Zeng Z, Xiong W, Zhang S, Guo C. AFAP1-AS1: a rising star among oncogenic long non-coding RNAs. Sci China Life Sci. 2021 Oct; 64(10):1602-1611. PMID: [33999309](//www.ncbi.nlm.nih.gov/pubmed/33999309).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33999309/citedby/) Fields:

Bio BiologySci Science

Translation:HumansCells

  24. Li L, Xiong F, Wang Y, Zhang S, Gong Z, Li X, He Y, Shi L, Wang F, Liao Q, Xiang B, Zhou M, Li X, **Li Y** , Li G, Zeng Z, Xiong W, Guo C. What are the applications of single-cell RNA sequencing in cancer research: a systematic review. J Exp Clin Cancer Res. 2021 May 11; 40(1):163. PMID: [33975628](//www.ncbi.nlm.nih.gov/pubmed/33975628); PMCID: [PMC8111731](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8111731).

Citations:
[10](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33975628/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  25. Wang M, Dai M, Wang D, Tang T, Xiong F, Xiang B, Zhou M, Li X, **Li Y** , Xiong W, Li G, Zeng Z, Guo C. The long noncoding RNA AATBC promotes breast cancer migration and invasion by interacting with YBX1 and activating the YAP1/Hippo signaling pathway. Cancer Lett. 2021 08 01; 512:60-72. PMID: [33951538](//www.ncbi.nlm.nih.gov/pubmed/33951538).

Citations:
[13](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33951538/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  26. Tan F, Zhao M, Xiong F, Wang Y, Zhang S, Gong Z, Li X, He Y, Shi L, Wang F, Xiang B, Zhou M, Li X, **Li Y** , Li G, Zeng Z, Xiong W, Guo C. N6-methyladenosine-dependent signalling in cancer progression and insights into cancer therapies. J Exp Clin Cancer Res. 2021 Apr 29; 40(1):146. PMID: [33926508](//www.ncbi.nlm.nih.gov/pubmed/33926508); PMCID: [PMC8082653](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8082653).

Citations:
[10](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33926508/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  27. Wang Y, Mo Y, Peng M, Zhang S, Gong Z, Yan Q, Tang Y, He Y, Liao Q, Li X, Wu X, Xiang B, Zhou M, **Li Y** , Li G, Li X, Zeng Z, Guo C, Xiong W. The influence of circular RNAs on autophagy and disease progression. Autophagy. 2022 02; 18(2):240-253. PMID: [33904341](//www.ncbi.nlm.nih.gov/pubmed/33904341); PMCID: [PMC8942425](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8942425).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33904341/citedby/) Fields:

Cel Cell Biology

Translation:Humans

  28. Fan C, Qu H, Wang X, Sobhani N, Wang L, Liu S, Xiong W, Zeng Z, **Li Y**. Cancer/testis antigens: from serology to mRNA cancer vaccine. Semin Cancer Biol. 2021 11; 76:218-231. PMID: [33910064](//www.ncbi.nlm.nih.gov/pubmed/33910064).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33910064/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimals

  29. Tan Z, Zou Y, Zhu M, Luo Z, Wu T, Zheng C, Xie A, Wang H, Fang S, Liu S, **Li Y** , Lu Z. Carnitine palmitoyl transferase 1A is a novel diagnostic and predictive biomarker for breast cancer. BMC Cancer. 2021 Apr 15; 21(1):409. PMID: [33858374](//www.ncbi.nlm.nih.gov/pubmed/33858374); PMCID: [PMC8048260](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8048260).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33858374/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  30. [Yu X](https://profiles.viictr.org/profile/28999565), Li W, Deng Q, Liu H, Wang X, Hu H, Cao Y, [Xu-Monette ZY](https://profiles.viictr.org/profile/17440027), Li L, Zhang M, Lu Z, [Young KH](https://profiles.viictr.org/profile/12582816), **Li Y**. MYD88 L265P elicits mutation-specific ubiquitination to drive NF-?B activation and lymphomagenesis. Blood. 2021 03 25; 137(12):1615-1627. PMID: [33025009](//www.ncbi.nlm.nih.gov/pubmed/33025009); PMCID: [PMC7995293](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7995293).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33025009/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  31. Sobhani N, Tardiel-Cyril DR, Davtyan A, Generali D, Roudi R, **Li Y**. CTLA-4 in Regulatory T Cells for Cancer Immunotherapy. Cancers (Basel). 2021 Mar 22; 13(6). PMID: [33809974](//www.ncbi.nlm.nih.gov/pubmed/33809974); PMCID: [PMC8005092](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8005092).

Citations:
[23](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33809974/citedby/)

  32. Wang Y, Gali VL, [Xu-Monette ZY](https://profiles.viictr.org/profile/17440027), Sano D, [Thomas SK](https://profiles.viictr.org/profile/12583777), [Weber DM](https://profiles.viictr.org/profile/12582903), Zhu F, Fang X, Deng M, Zhang M, [Hagemeister FB](https://profiles.viictr.org/profile/12583270), **Li Y** , [Orlowski RZ](https://profiles.viictr.org/profile/12583884), Lee HC, [Young KH](https://profiles.viictr.org/profile/12582816). Molecular and genetic biomarkers implemented from next-generation sequencing provide treatment insights in clinical practice for Waldenstr?m macroglobulinemia. Neoplasia. 2021 04; 23(4):361-374. PMID: [33735664](//www.ncbi.nlm.nih.gov/pubmed/33735664); PMCID: [PMC7985670](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7985670).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33735664/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  33. Zhang Y, Wang D, Peng M, Tang L, Ouyang J, Xiong F, Guo C, Tang Y, Zhou Y, Liao Q, Wu X, Wang H, Yu J, **Li Y** , Li X, Li G, Zeng Z, Tan Y, Xiong W. Single-cell RNA sequencing in cancer research. J Exp Clin Cancer Res. 2021 Mar 01; 40(1):81. PMID: [33648534](//www.ncbi.nlm.nih.gov/pubmed/33648534); PMCID: [PMC7919320](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7919320).

Citations:
[17](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33648534/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  34. Wei X, Chen Y, Jiang X, Peng M, Liu Y, Mo Y, Ren D, Hua Y, Yu B, Zhou Y, Liao Q, Wang H, Xiang B, Zhou M, Li X, Li G, **Li Y** , Xiong W, Zeng Z. Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments. Mol Cancer. 2021 01 04; 20(1):7. PMID: [33397409](//www.ncbi.nlm.nih.gov/pubmed/33397409); PMCID: [PMC7784348](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7784348).

Citations:
[39](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33397409/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCells

  35. Schaafsma E, Zhao Y, Zhang L, **Li Y** , Cheng C. MYC Activity Inference Captures Diverse Mechanisms of Aberrant MYC Pathway Activation in Human Cancers. Mol Cancer Res. 2021 03; 19(3):414-428. PMID: [33234576](//www.ncbi.nlm.nih.gov/pubmed/33234576); PMCID: [PMC7925347](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7925347).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33234576/citedby/) Fields:

Cel Cell BiologyMol Molecular BiologyNeo Neoplasms

Translation:Humans

  36. Deng M, [Xu-Monette ZY](https://profiles.viictr.org/profile/17440027), [Pham LV](https://profiles.viictr.org/profile/12583723), Wang X, Tzankov A, Fang X, Zhu F, Visco C, Bhagat G, Dybkaer K, Chiu A, Tam W, Zu Y, Hsi ED, You H, Huh J, Ponzoni M, Parsons BM, [Hagemeister F](https://profiles.viictr.org/profile/12583270), van Krieken JH, Winter JN, **Li Y** , Xu B, Liu P, [Young KH](https://profiles.viictr.org/profile/12582816), Ferreri AJM, M?ller MB, Piris MA. Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents. Mol Cancer Res. 2021 02; 19(2):249-260. PMID: [33154093](//www.ncbi.nlm.nih.gov/pubmed/33154093); PMCID: [PMC8092941](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8092941).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33154093/citedby/) Fields:

Cel Cell BiologyMol Molecular BiologyNeo Neoplasms

Translation:HumansCells

  37. Deng M, Zhang M, [Xu-Monette ZY](https://profiles.viictr.org/profile/17440027), [Pham LV](https://profiles.viictr.org/profile/12583723), Tzankov A, Visco C, Fang X, Bhagat G, Zhu F, Dybkaer K, Chiu A, Tam W, Zu Y, Hsi ED, Choi WWL, Huh J, Ponzoni M, Parsons BM, van Krieken JH, Winter JN, [Hagemeister F](https://profiles.viictr.org/profile/12583270), Alinari L, **Li Y** , [Andreeff M](https://profiles.viictr.org/profile/12582880), Xu B, [Young KH](https://profiles.viictr.org/profile/12582816), Ferreri AJM, M?ller MB, Piris MA. XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53. J Hematol Oncol. 2020 11 04; 13(1):148. PMID: [33148342](//www.ncbi.nlm.nih.gov/pubmed/33148342); PMCID: [PMC7641823](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7641823).

Citations:
[10](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33148342/citedby/) Fields:

Hem HematologyNeo Neoplasms

Translation:HumansCells

  38. Wu Y, Wang D, Wei F, Xiong F, Zhang S, Gong Z, Shi L, Li X, Xiang B, Ma J, Deng H, He Y, Liao Q, Zhang W, Li X, **Li Y** , Guo C, Zeng Z, Li G, Xiong W. EBV-miR-BART12 accelerates migration and invasion in EBV-associated cancer cells by targeting tubulin polymerization-promoting protein 1. FASEB J. 2020 12; 34(12):16205-16223. PMID: [33094864](//www.ncbi.nlm.nih.gov/pubmed/33094864).

Citations:
[13](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33094864/citedby/) Fields:

Bio BiologyPhy Physiology

Translation:HumansCells

  39. Li P, Zhang S, Mo Y, Zhang L, Wang Y, Xiong F, Zhang S, Liu J, Xu Y, Zeng Z, Xiong W, **Li Y** , Gong Z. Long non-coding RNA expression profiles and related regulatory networks in areca nut chewing-induced tongue squamous cell carcinoma. Oncol Lett. 2020 Dec; 20(6):302. PMID: [33093911](//www.ncbi.nlm.nih.gov/pubmed/33093911); PMCID: [PMC7573881](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7573881).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33093911/citedby/)

  40. Fan C, Wang J, Tang Y, Zhang S, Xiong F, Guo C, Zhou Y, Li Z, Li X, **Li Y** , Li G, Zeng Z, Xiong W. Upregulation of long non-coding RNA LOC284454 may serve as a new serum diagnostic biomarker for head and neck cancers. BMC Cancer. 2020 Sep 24; 20(1):917. PMID: [32972383](//www.ncbi.nlm.nih.gov/pubmed/32972383); PMCID: [PMC7517628](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7517628).

Citations:
[16](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32972383/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  41. Fan C, Qu H, Xiong F, Tang Y, Tang T, Zhang L, Mo Y, Li X, Guo C, Zhang S, Gong Z, Li Z, Xiang B, Deng H, Zhou M, Liao Q, Zhou Y, Li X, **Li Y** , Li G, Wang F, Zeng Z. CircARHGAP12 promotes nasopharyngeal carcinoma migration and invasion via ezrin-mediated cytoskeletal remodeling. Cancer Lett. 2021 01 01; 496:41-56. PMID: [32931883](//www.ncbi.nlm.nih.gov/pubmed/32931883).

Citations:
[21](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32931883/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCells

  42. Dai S, Mo Y, Wang Y, Xiang B, Liao Q, Zhou M, Li X, **Li Y** , Xiong W, Li G, Guo C, Zeng Z. Chronic Stress Promotes Cancer Development. Front Oncol. 2020; 10:1492. PMID: [32974180](//www.ncbi.nlm.nih.gov/pubmed/32974180); PMCID: [PMC7466429](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7466429).

Citations:
[30](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32974180/citedby/)

  43. Fan C, Zhang S, Gong Z, Li X, Xiang B, Deng H, Zhou M, Li G, **Li Y** , Xiong W, Zeng Z, Li X. Emerging role of metabolic reprogramming in tumor immune evasion and immunotherapy. Sci China Life Sci. 2021 Apr; 64(4):534-547. PMID: [32815067](//www.ncbi.nlm.nih.gov/pubmed/32815067).

Citations:
[18](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32815067/citedby/) Fields:

Bio BiologySci Science

Translation:HumansAnimalsCells

  44. Liu M, Wang X, Li W, Yu X, Flores-Villanueva P, [Xu-Monette ZY](https://profiles.viictr.org/profile/17440027), Li L, Zhang M, [Young KH](https://profiles.viictr.org/profile/12582816), Ma X, **Li Y**. Targeting PD-L1 in non-small cell lung cancer using CAR T cells. Oncogenesis. 2020 Aug 13; 9(8):72. PMID: [32792499](//www.ncbi.nlm.nih.gov/pubmed/32792499); PMCID: [PMC7426958](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7426958).

Citations:
[15](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32792499/citedby/)

  45. Flores-Villanueva P, Sobhani N, Wang X, **Li Y**. MR1-Restricted T Cells in Cancer Immunotherapy. Cancers (Basel). 2020 Aug 03; 12(8). PMID: [32756356](//www.ncbi.nlm.nih.gov/pubmed/32756356); PMCID: [PMC7464881](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7464881).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32756356/citedby/)

  46. [Xu-Monette ZY](https://profiles.viictr.org/profile/17440027), Zhang H, Zhu F, Tzankov A, Bhagat G, Visco C, Dybkaer K, Chiu A, Tam W, Zu Y, Hsi ED, You H, Huh J, Ponzoni M, Parsons BM, van Krieken JH, Winter JN, [Hagemeister FB](https://profiles.viictr.org/profile/12583270), Shahbaba B, De Dios I, Zhang H, **Li Y** , Xu B, Albitar M, [Young KH](https://profiles.viictr.org/profile/12582816), Ferreri AJM, M?ller MB, Piris MA. A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL. Blood Adv. 2020 07 28; 4(14):3391-3404. PMID: [32722783](//www.ncbi.nlm.nih.gov/pubmed/32722783); PMCID: [PMC7391158](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7391158).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32722783/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  47. Tang T, Yang L, Cao Y, Wang M, Zhang S, Gong Z, Xiong F, He Y, Zhou Y, Liao Q, Xiang B, Zhou M, Guo C, Li X, **Li Y** , Xiong W, Li G, Zeng Z. LncRNA AATBC regulates Pinin to promote metastasis in nasopharyngeal carcinoma. Mol Oncol. 2020 09; 14(9):2251-2270. PMID: [32364663](//www.ncbi.nlm.nih.gov/pubmed/32364663); PMCID: [PMC7463349](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7463349).

Citations:
[27](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32364663/citedby/) Fields:

Mol Molecular BiologyNeo Neoplasms

Translation:HumansAnimalsCells

  48. Sobhani N, D'Angelo A, Wang X, [Young KH](https://profiles.viictr.org/profile/12582816), Generali D, **Li Y**. Mutant p53 as an Antigen in Cancer Immunotherapy. Int J Mol Sci. 2020 Jun 08; 21(11). PMID: [32521648](//www.ncbi.nlm.nih.gov/pubmed/32521648); PMCID: [PMC7312027](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7312027).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32521648/citedby/) Fields:

Bio BiochemistryChe ChemistryMol Molecular Biology

Translation:HumansAnimalsCells

  49. Zhou H, [Xu-Monette ZY](https://profiles.viictr.org/profile/17440027), Xiao L, Strati P, [Hagemeister FB](https://profiles.viictr.org/profile/12583270), He Y, Chen H, Li Y, Manyam GC, **Li Y** , Piris MA, [Young KH](https://profiles.viictr.org/profile/12582816), Montes-Moreno S. Prognostic factors, therapeutic approaches, and distinct immunobiologic features in patients with primary mediastinal large B-cell lymphoma on long-term follow-up. Blood Cancer J. 2020 05 04; 10(5):49. PMID: [32366834](//www.ncbi.nlm.nih.gov/pubmed/32366834); PMCID: [PMC7198569](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7198569).

Citations:
[10](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32366834/citedby/) Fields:

All Allergy and ImmunologyHem HematologyNeo Neoplasms

Translation:HumansCells

  50. [Yu X](https://profiles.viictr.org/profile/28999565), Li W, Liu H, Deng Q, Wang X, Hu H, [Xu-Monette ZY](https://profiles.viictr.org/profile/17440027), Xiong W, Lu Z, [Young KH](https://profiles.viictr.org/profile/12582816), Wang W, **Li Y**. Ubiquitination of the DNA-damage checkpoint kinase CHK1 by TRAF4 is required for CHK1 activation. J Hematol Oncol. 2020 05 01; 13(1):40. PMID: [32357935](//www.ncbi.nlm.nih.gov/pubmed/32357935); PMCID: [PMC7193419](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7193419).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32357935/citedby/) Fields:

Hem HematologyNeo Neoplasms

Translation:HumansAnimalsCells

  51. Wang D, Zeng Z, Zhang S, Xiong F, He B, Wu Y, Li W, Tang L, Wei F, Xiang B, Li Z, Zhou Y, Zhou M, Li X, **Li Y** , Li G, Xiong W, Guo C. Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell proliferation through the LOC553103-STMN1 axis. FASEB J. 2020 06; 34(6):8012-8027. PMID: [32306460](//www.ncbi.nlm.nih.gov/pubmed/32306460).

Citations:
[22](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32306460/citedby/) Fields:

Bio BiologyPhy Physiology

Translation:HumansAnimalsCells

  52. Navid S, Fan C, O Flores-Villanueva P, Generali D, **Li Y**. The Fibroblast Growth Factor Receptors in Breast Cancer: from Oncogenesis to Better Treatments. Int J Mol Sci. 2020 Mar 16; 21(6). PMID: [32188012](//www.ncbi.nlm.nih.gov/pubmed/32188012); PMCID: [PMC7139621](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7139621).

Citations:
[21](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32188012/citedby/) Fields:

Bio BiochemistryChe ChemistryMol Molecular Biology

Translation:Humans

  53. Wang D, Tang L, Wu Y, Fan C, Zhang S, Xiang B, Zhou M, Li X, **Li Y** , Li G, Xiong W, Zeng Z, Guo C. Abnormal X chromosome inactivation and tumor development. Cell Mol Life Sci. 2020 Aug; 77(15):2949-2958. PMID: [32040694](//www.ncbi.nlm.nih.gov/pubmed/32040694); PMCID: [PMC11104905](//www.ncbi.nlm.nih.gov/pmc/articles/PMC11104905).

Citations:
[16](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32040694/citedby/) Fields:

Cel Cell BiologyMol Molecular Biology

Translation:HumansCells

  54. Wu P, Mo Y, Peng M, Tang T, Zhong Y, Deng X, Xiong F, Guo C, Wu X, **Li Y** , Li X, Li G, Zeng Z, Xiong W. Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA. Mol Cancer. 2020 02 04; 19(1):22. PMID: [32019587](//www.ncbi.nlm.nih.gov/pubmed/32019587); PMCID: [PMC6998289](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6998289).

Citations:
[128](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32019587/citedby/)
Fields:

Neo Neoplasms

Translation:HumansAnimals

  55. Ren D, Hua Y, Yu B, Ye X, He Z, Li C, Wang J, Mo Y, Wei X, Chen Y, Zhou Y, Liao Q, Wang H, Xiang B, Zhou M, Li X, Li G, **Li Y** , Zeng Z, Xiong W. Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy. Mol Cancer. 2020 01 30; 19(1):19. PMID: [32000802](//www.ncbi.nlm.nih.gov/pubmed/32000802); PMCID: [PMC6993488](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6993488).

Citations:
[63](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32000802/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimals

  56. Deng Q, Hu H, [Yu X](https://profiles.viictr.org/profile/28999565), Liu S, Wang L, Chen W, Zhang C, Zeng Z, Cao Y, [Xu-Monette ZY](https://profiles.viictr.org/profile/17440027), Li L, Zhang M, Rosenfeld S, Bao S, Hsi E, [Young KH](https://profiles.viictr.org/profile/12582816), Lu Z, **Li Y**. Tissue-specific microRNA expression alters cancer susceptibility conferred by a TP53 noncoding variant. Nat Commun. 2019 11 07; 10(1):5061. PMID: [31699989](//www.ncbi.nlm.nih.gov/pubmed/31699989); PMCID: [PMC6838078](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6838078).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31699989/citedby/) Fields:

Bio BiologySci Science

Translation:HumansAnimalsCells

  57. [Xu-Monette ZY](https://profiles.viictr.org/profile/17440027), Li J, Xia Y, Crossley B, Bremel RD, Miao Y, Xiao M, Snyder T, Manyam GC, Tan X, Zhang H, Visco C, Tzankov A, Dybkaer K, Bhagat G, Tam W, You H, Hsi ED, van Krieken JH, Huh J, Ponzoni M, Winter JN, Medeiros JT, Xu B, **Li Y** , Kirsch I, [Young KH](https://profiles.viictr.org/profile/12582816), Ferreri AJM, M?ller MB, Piris MA. Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies. J Immunother Cancer. 2019 10 22; 7(1):272. PMID: [31640780](//www.ncbi.nlm.nih.gov/pubmed/31640780); PMCID: [PMC6806565](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6806565).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31640780/citedby/) Fields:

Neo NeoplasmsThe Therapeutics

Translation:HumansCells

  58. Miao Y, [Medeiros LJ](https://profiles.viictr.org/profile/12583326), **Li Y** , Li J, [Young KH](https://profiles.viictr.org/profile/12582816). Genetic alterations and their clinical implications in DLBCL. Nat Rev Clin Oncol. 2019 10; 16(10):634-652. PMID: [31127191](//www.ncbi.nlm.nih.gov/pubmed/31127191).

Citations:
[61](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31127191/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  59. Peng M, Mo Y, Wang Y, Wu P, Zhang Y, Xiong F, Guo C, Wu X, **Li Y** , Li X, Li G, Xiong W, Zeng Z. Neoantigen vaccine: an emerging tumor immunotherapy. Mol Cancer. 2019 08 23; 18(1):128. PMID: [31443694](//www.ncbi.nlm.nih.gov/pubmed/31443694); PMCID: [PMC6708248](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6708248).

Citations:
[127](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31443694/citedby/)
Fields:

Neo Neoplasms

Translation:HumansAnimals

  60. Wang L, Deng Q, Hu H, Liu M, Gong Z, Zhang S, [Xu-Monette ZY](https://profiles.viictr.org/profile/17440027), Lu Z, [Young KH](https://profiles.viictr.org/profile/12582816), Ma X, **Li Y**. Glyphosate induces benign monoclonal gammopathy and promotes multiple myeloma progression in mice. J Hematol Oncol. 2019 07 05; 12(1):70. PMID: [31277689](//www.ncbi.nlm.nih.gov/pubmed/31277689); PMCID: [PMC6612199](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6612199).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31277689/citedby/) Fields:

Hem HematologyNeo Neoplasms

Translation:HumansAnimals

This graph shows the total number of publications by year. To see the data as
text, click here.

![Bar chart showing 60 publications over 6 distinct years, with a maximum of
21 publications in
2020](//chart.googleapis.com/chart?chs=595x100&chf=bg,s,ffffff|c,s,ffffff&chxt=x,y&chxl=0:|'94||'96||'98||'00||'02||'04||'06||'08||'10||'12||'14||'16||'18||'20||'22||'24|1:|0|21&cht=bvs&chd=t:0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,100,71,19,52,19&chdl=Publications&chco=80B1D3&chbh=10)

This graph shows the total number of publications by year. To return to the
graph, click here.

Year| Publications  
---|---  
2019| 5  
2020| 21  
2021| 15  
2022| 4  
2023| 11  
2024| 4  
  
This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

Start with: newest oldest Include: line numbers double spacing all authors
publication IDs

LI's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (212)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

Derived automatically from this person's publications.

  * [Antigens, Neoplasm](https://profiles.viictr.org/profile/246632)
  * [Carcinogenesis](https://profiles.viictr.org/profile/27547044)
  * [Cancer Vaccines](https://profiles.viictr.org/profile/253590)
  * [Tumor Suppressor Protein p53](https://profiles.viictr.org/profile/245072)
  * [Ubiquitination](https://profiles.viictr.org/profile/250975)

[Explore](https://profiles.viictr.org/profile/28999515/198)

_

Co-Authors (21)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People in Profiles who have published with this person.

  * [YOUNG, KEN HE](https://profiles.viictr.org/profile/12582816)
  * [YU, XINFANG](https://profiles.viictr.org/profile/28999565)
  * [Chai, Dafei](https://profiles.viictr.org/profile/35895164)
  * [XU-MONETTE, ZIJUN](https://profiles.viictr.org/profile/17440027)
  * [HAGEMEISTER, FREDRICK B](https://profiles.viictr.org/profile/12583270)

[Explore](https://profiles.viictr.org/profile/28999515/345)

_

Similar People (60)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People who share similar concepts with this person.

  * [CALIN, GEORGE A](https://profiles.viictr.org/profile/12583509)
  * [HUNG, MIEN-CHIE](https://profiles.viictr.org/profile/12582486)
  * [MEDEIROS, L JEFFREY](https://profiles.viictr.org/profile/12583326)
  * [KANTARJIAN, HAGOP M](https://profiles.viictr.org/profile/12582901)
  * [CASTILLO, JORGE](https://profiles.viictr.org/profile/38266317)

[Explore](https://profiles.viictr.org/profile/28999515/476)

_

Same Department [ ![Expand
Description](https://profiles.viictr.org/Framework/Images/info.png)
](JavaScript:toggleVisibility\('sdDescript'\);)

People who are also in this person's primary department.

  * [AMOS, CHRIS](https://profiles.viictr.org/profile/23372697)
  * [BERNSTAM, ELMER](https://profiles.viictr.org/profile/30882399)
  * [MITSIADES, M.D., NICHOLAS](https://profiles.viictr.org/profile/266621)
  * [PENG, BO](https://profiles.viictr.org/profile/30797003)
  * [YU, XINFANG](https://profiles.viictr.org/profile/28999565)

[Explore](https://profiles.viictr.org/search/default.aspx?searchtype=people&searchfor=&SearchRequest=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)

_

